文献速递心境障碍

氯胺酮对难治性抑郁个体症状及症状网络的影响:一项随机对照试验

Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression.
PubMed 文献 · Br J Psychiatry · 2025-05-13

该研究为一项随机对照试验的二次分析,纳入152名难治性抑郁成人,比较单次静脉氯胺酮0.5 mg/kg(n=103)与生理盐水(n=49)在输注后早期和晚期的症状变化及症状网络改变。结果显示氯胺酮在早期对悲伤症状改善最大,症状网络连接性增加,悲伤和乏力在输注后第一周持续改善,自杀意念改善在3-4周才出现。

要点

  • 氯胺酮对难治性抑郁所有症状均有改善,但对悲伤症状效果最大,且早期即显现。
  • 氯胺酮输注后症状网络连接性迅速增加,残留症状间关系增强。
  • 自杀意念的改善出现较晚,在输注后3-4周才显现。

核心结论

  • 氯胺酮改善所有抑郁症状,但对悲伤症状效果最大,且在治疗后立即和第一周内均显著。
  • 氯胺酮快速改变症状网络拓扑结构,增强残留症状间的相互关系。
  • 氯胺酮对自杀症状的疗效出现较晚,在输注后3-4周才显现。

研究设计与样本

  • 该研究为随机对照试验的二次分析,纳入152名难治性抑郁成人,其中38.8%基线有自杀意念。
  • 参与者随机接受单次40分钟静脉输注氯胺酮0.5 mg/kg(n=103)或生理盐水(n=49)。
  • 比较输注后早期(≤1天)和晚期(如2-30天)的症状变化,并使用网络分析识别氯胺酮治疗前后症状网络的变化。

主要发现

  • 在输注后早期,与生理盐水相比,氯胺酮对悲伤相关抑郁症状的改善最大。
  • 网络分析显示,氯胺酮输注后症状网络连接性增加。
  • 悲伤和乏力症状在输注后第一周持续改善,而自杀意念的改善在3-4周才首次出现。

临床怎么用

  • 氯胺酮治疗难治性抑郁时,应关注其对悲伤症状的快速改善效果。
  • 氯胺酮对自杀意念的改善可能延迟出现,需在治疗后数周内持续评估。
  • 症状网络分析提示氯胺酮可能通过增强症状间联系影响抑郁病理,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding the effects of ketamine on depressive symptoms could help identify which patients might benefit and clarify its mechanism of action in both the early (≤1 day post-infusion) and late (e.g. 2-30 days post-infusion) post-infusion periods. Symptom network analyses could provide complementary information regarding relationships between symptoms. AIMS: To identify the effects of ketamine on symptom-level changes in depression across both the early and late post-infusion periods and on depressive symptom network changes. METHODS: In this secondary analysis of 152 adults with treatment-resistant depression (with 38.8% reporting suicidal ideation at baseline), we compared symptom changes in the early and late post-infusion periods between individuals randomised to a single 40 min infusion of intravenous ketamine 0.5 mg/kg (n = 103) or saline (n = 49) and identified changes in symptom networks between pre- and post-ketamine treatment using network analyses. RESULTS: In the early post-infusion period, the greatest improvement (comparing ketamine with saline) was in depressive symptoms related to sadness. In network analyses, symptom network connectivity increased following ketamine infusion. Symptoms of sadness and lassitude showed persistent improvement in the first week post-infusion, whereas improvements in suicidal thoughts first emerged 3-4 weeks post-infusion. CONCLUSION: Ketamine improved all symptoms but showed the greatest effect on symptoms of sadness, both immediately and in the initial week after treatment. Ketamine also rapidly altered the topology of symptom networks, strengthening interrelationships between residual symptoms. The efficacy of ketamine (compared with saline) regarding suicidal symptoms emerged later. Our findings suggest potentially divergent efficacy, time courses and mechanisms for different symptoms of depression.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hossein S, Rengasamy M, Uzamere A, et al. Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depression. Br J Psychiatry. 2025. PMID: 40355133. doi:10.1192/bjp.2024.276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。